Cigna Group (NYSE:CI) Given New $346.00 Price Target at Piper Sandler

Cigna Group (NYSE:CI) had its price objective trimmed by Piper Sandler from $370.00 to $346.00 in a research report report published on Wednesday morning,MarketScreener reports. The firm currently has an overweight rating on the health services provider’s stock.

Several other research analysts also recently weighed in on the stock. Royal Bank Of Canada upped their target price on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Wells Fargo & Company increased their price objective on shares of Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research note on Friday, May 1st. Mizuho set a $330.00 price objective on shares of Cigna Group in a research note on Friday, May 1st. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $338.30.

Cigna Group Price Performance

Shares of CI stock opened at $271.03 on Wednesday. The company has a market capitalization of $71.70 billion, a PE ratio of 11.49, a price-to-earnings-growth ratio of 0.98 and a beta of 0.28. The firm has a fifty day simple moving average of $278.88 and a 200-day simple moving average of $277.07. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a twelve month low of $239.51 and a twelve month high of $338.89.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities research analysts anticipate that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio is 26.45%.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company’s stock.

Institutional Trading of Cigna Group

A number of institutional investors and hedge funds have recently modified their holdings of the business. DV Trading LLC raised its holdings in shares of Cigna Group by 187.5% during the first quarter. DV Trading LLC now owns 920 shares of the health services provider’s stock worth $245,000 after purchasing an additional 600 shares during the period. Parallel Advisors LLC raised its holdings in shares of Cigna Group by 26.1% during the first quarter. Parallel Advisors LLC now owns 3,568 shares of the health services provider’s stock worth $952,000 after purchasing an additional 738 shares during the period. NewEdge Advisors LLC raised its holdings in shares of Cigna Group by 47.8% during the first quarter. NewEdge Advisors LLC now owns 34,277 shares of the health services provider’s stock worth $9,143,000 after purchasing an additional 11,085 shares during the period. Caerus Investment Advisors LLC acquired a new stake in shares of Cigna Group during the first quarter worth $294,000. Finally, First Nebraska Trust Co acquired a new stake in shares of Cigna Group during the first quarter worth $204,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.